ArticleFrontiers in oncology2026

Trastuzumab deruxtecan in HER2-positive metastatic breast cancer with severe hepatic dysfunction: a case report and narrative literature review.

Giuseppe Saltalamacchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.